top of page
  • Writer's picturePlaqueTec

Profiling plaque to guide treatment of coronary artery disease

Published in Cardiovascular News, Dr Stephen Hoole, Chief Investigator of our BIOPATTERN trial and Consultant Cardiologist at Royal Papworth Hospital, shares his insight on how the findings from the trial could pave the way for a precision approach in the treatment of cardiovascular disease.

Stephen covers:

  • The concept of 'precision medicine' — how does this differ from current models of care?

  • How does PlaqueTec's Liquid Biopsy System (LBS) work?

  • How straightforward is the sample collection process?

  • What are the aims of the BIOPATTERN trial?


bottom of page